Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating deficiency fire and phlegm stagnation syndrome lymphatic system diseases

A composition and a technology of traditional Chinese medicine, applied in the field of traditional Chinese medicine compositions, can solve the traditional Chinese medicine composition that does not see the disease of the lymphatic system with deficiency of fire and phlegm, does not record the specific syndrome type of the lymphatic system disease, and does not record the compatibility relationship between the ruler, minister, assistant and envoy of the traditional Chinese medicine composition, etc. problem, to achieve excellent therapeutic effect, less toxic and side effects, and high cure rate.

Inactive Publication Date: 2021-04-02
重庆市淋宝生物科技有限公司
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Although the Chinese patent application CN107412358A has recorded a kind of Chinese medicine composition for the treatment of lymphatic system diseases, this application neither records the compatibility relationship of the monarch, minister and assistant of the Chinese medicine composition, nor does it record the lymphatic system diseases (such as lymphatic inflammation) targeted by the Chinese medicine composition. , lymphatic tuberculosis) specific syndrome type
[0008] At present, there is no report of a traditional Chinese medicine composition for the treatment of lymphatic system diseases of asthenic fire and phlegm syndrome

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating deficiency fire and phlegm stagnation syndrome lymphatic system diseases
  • Pharmaceutical composition for treating deficiency fire and phlegm stagnation syndrome lymphatic system diseases
  • Pharmaceutical composition for treating deficiency fire and phlegm stagnation syndrome lymphatic system diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] The preparation of embodiment 1 pharmaceutical composition of the present invention

[0044] 1. Prescription

[0045] Composition a: 300g Tiankuizi, 300g Prunella vulgaris, 450g white ground cucumber, 250g Polygonum multiflorum, 200g honeysuckle;

[0046] Composition b: 400g of icegrass, 300g of Prunella vulgaris, 100g of seaweed, 200g of Nocturna vine, 150g of Schizonepeta, 200g of Lonicera vine, 100g of Akebia.

[0047] 2. Preparation method

[0048] (1) According to the prescription amount of composition a, take tiankuizi, Prunella vulgaris, cucumber, Radix Polygoni Multiflori, and honeysuckle, and pass through a 100-mesh sieve after crushing to obtain powder;

[0049] (2) According to the prescription quantity of composition b, take Lingbingcao, Prunella vulgaris, seaweed, night cross vine, nepeta, honeysuckle vine, akebia, add 2-3 times the weight of water, bring to a boil with high heat, and simmer for 1- After 2 hours, filter and collect the decoction; add 2 / 3...

experiment example 1

[0052] Clinical case statistics of experimental example 1 pharmaceutical composition of the present invention to lymphadenitis therapeutic effect

[0053] 1. TCM diagnostic criteria

[0054] Deficiency-fire phlegm syndrome lymphitis: multiple swollen nuclei in the neck, under the ear or under the armpits, no pain or itching, unchanged skin color, dizziness and tinnitus, or accompanied by bitter mouth and dry throat, or yellow and white phlegm, chest and abdomen distension, Dry stool, short red urine, red tongue with yellow fur, stringy pulse. The swollen nuclei are as large as soybeans, one or several, which can appear simultaneously or successively. The skin color does not change, the texture is slightly hard, the surface is smooth, neither hot nor painful, and can be moved when pushed.

[0055] 2. Standard of treatment

[0056] Cure standard: Symptoms disappear completely.

[0057] Effective standard: more than 80% of symptoms disappear.

[0058] 3. Treatment method

[...

experiment example 2

[0062] Experimental example 2 the clinical case statistics of pharmaceutical composition of the present invention to lymphatic tuberculosis therapeutic effect

[0063] 1. TCM diagnostic criteria

[0064] Deficiency-fire phlegm syndrome lymphatic tuberculosis: multiple swollen nuclei in the neck, under the ear or under the armpit, painless or itchy, skin color unchanged, dizziness and tinnitus, or accompanied by bitter mouth and dry throat, or yellow and white phlegm, chest and abdomen distension, Dry stool, short red urine, red tongue with yellow fur, stringy pulse. The nuclear mass adheres to the epidermis, and sometimes several nuclear masses fuse with each other to form a large mass, which cannot be moved and is painful when pushed. When further purulent, the superficial skin turns dark red, slightly hot, and there is a slight fluctuating sensation when pressed.

[0065] 2. Standard of treatment

[0066] Cure standard: Symptoms disappear completely.

[0067] Effective s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating deficiency fire and phlegm stagnation syndrome lymphatic system diseases. The pharmaceutical composition is a preparation prepared from the following raw materials in parts by weight: 280-320 parts of radix semiaquilegiae, 580-620 parts of selfheal, 430-470 parts of viola diffusa, 230-270 parts of polygonum multiflorum, 180-220 parts of honeysuckle flowers, 380-420 parts of raMosia rubescens, 80-120 parts of seaweed, 180-220 parts of tuber fleeceflower stems, 130-170 parts of herba schizonepetae, 180-220 parts of caulis lonicerae and 80-120 parts of akebia stems. The composition has excellent treatment effects on deficiency fire and phlegm stagnation syndrome lymphatic system diseases (including lymphadenitis, scrofula and lymphoma), and is high in cure rate and small in toxic and side effects. The pharmaceutical composition disclosed by the invention has wide application prospects in preparation of medicines for preventing and / or treating the deficiency fire and phlegm stagnation syndrome lymphatic system diseases.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine compositions, and in particular relates to a medicinal composition for treating lymphatic system diseases with asthenic fire and phlegm stagnation syndrome. Background technique [0002] Scrofula, also known as "Scrofula neck" or "mouse sore", is a disease of the lymphatic system that occurs in the neck. The name "scrofula" first appeared more than 2,000 years ago in the "Huangdi Neijing" Lingshu·Cold and Heat chapter: "Cold and heat scrofula is found in the neck and armpits." Nuclei of different sizes can be palpable between the skin and flesh of the neck. The ones are scrofula, and the larger ones are scrofula. Because they are connected in series, they are coherent like a string of beads, so they are called scrofula. The characteristics of this disease are mostly seen in young and middle-aged people. It is like beans at the beginning, without pain, and gradually increases, and it is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/86A61P29/00A61P31/06A61P35/00A61P43/00
CPCA61K36/02A61K36/185A61K36/355A61K36/53A61K36/536A61K36/538A61K36/704A61K36/71A61K36/86A61P29/00A61P31/06A61P35/00A61P43/00A61K2300/00
Inventor 莫云伍松满其明李建兴邬厚丰
Owner 重庆市淋宝生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com